GlassScriptPhysician profile
Elston Royce Johnson
NPI 1568854065
$5,256.78
in general payments reported to CMS, 2019-2025
30 companies · $1,504 in 2025
The $1,504 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $809 · 2020: $236 · 2021: $239 · 2022: $629 · 2023: $745 · 2024: $1,095 · 2025: $1,504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,264 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,263.50 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $897.77 | 2019-2025 | Farxiga, Brilinta, Wainua |
| Boston Scientific Corporation | $890.27 | 2019-2025 | Watchman Flx, Cds - Other, Watchman Access System |
| Novartis Pharmaceuticals Corporation | $534.35 | 2022-2025 | |
| Amgen INC. | $491.82 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $461.91 | 2023-2025 | |
| Medtronic, INC. | $456.07 | 2022-2025 | Venaseal, Closurerfs, Closurefast |
| E.R. Squibb & Sons, L.L.C. | $190.32 | 2019-2025 | Eliquis, Camzyos |
| Novo Nordisk INC | $153.90 | 2023-2025 | Wegovy, Ozempic |
| Abiomed | $152.95 | 2024-2025 | Impella |
| Merck Sharp & Dohme LLC | $130.14 | 2022-2025 | Verquvo |
| Amarin Pharma, INC. | $125.48 | 2019 | |
| Janssen Pharmaceuticals, INC | $120.44 | 2021-2023 | Xarelto |
| Regeneron Healthcare Solutions, INC. | $81.14 | 2019-2023 | Dupixent |
| Edwards Lifesciences Corporation | $72.54 | 2024-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Ge Healthcare | $71.09 | 2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $63.98 | 2023-2025 | Nexletol |
| Abbott Laboratories | $56.90 | 2019-2024 | Mitraclip |
| Actelion Pharmaceuticals US, INC. | $50.74 | 2022-2024 | Opsumit, Uptravi |
| Bayer Healthcare Pharmaceuticals INC. | $33.78 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $31.19 | 2024 | Arcalyst |
| Terumo Medical Corporation | $27.42 | 2022 | |
| Atricure, INC. | $25.70 | 2023 | |
| Heartflow, INC. | $25.63 | 2024 | |
| Octapharma USA, INC. | $24.29 | 2025 | Fibryga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $17.32 | 2022 | |
| Lantheus Medical Imaging, INC. | $16.58 | 2019 | |
| W. L. Gore & Associates, INC. | $15.08 | 2025 | Gore Cardioform Septal Occluder |
| Cvrx, INC. | $14.67 | 2025 | Barostim Neo System |
| Altathera Pharmaceuticals LLC | $14.38 | 2024 | Sotalol Hydrochloride |
| American Regent | $8.93 | 2024 | Injectafer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elston Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.